Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies.

Source:http://linkedlifedata.com/resource/pubmed/id/17448179

Download in:

View as

General Info

PMID
17448179